Table 1.
Diagnostic Strategies | What Is? | How? |
---|---|---|
Screening | Detect mild forms of KC, and ectasia susceptibility, considering the refractive treatment and the impact on the cornea. | Placido-disk corneal topography, Scheimpflug tomography, OCT (or VHF US) segmental tomography, and biomechanical assessments. |
Diagnostic confirmation | Paradigm shift related to the management of ECD and access ectasia risk and progression to improve treatment. | Comprehensive clinical evaluation with multimodal imaging. |
Classification of ectasia | Group of disorders characterized by progressive thinning and following protruding of the corneal structure. | Integration of tomographic and biomechanical data with AI, genetics, and molecular biology. |
Staging | To prevent visual loss before it even occurs, with new treatment modalities. | ABCD + E ectasia/KC staging. |
Prognostic | Management of KC varies depending on the severity of the disease | Biomechanical parameters (SPA-1) and patient compliance. |
Keratoconus (KC), ectatic corneal diseases (ECD), artificial intelligence (AI).